Fact CheckerSign in

NCT07587411Enrolling by invitation

Stepped-Care Support for Children With Leukaemia

Developing a Stepped-Care Intervention for Emotional and Behavioral Health in Children With Leukemia: A Study Protocol

Source: ClinicalTrials.gov · Last updated 18 May 2026

Brief summary (registry, in English)

This study aims to develop, culturally adapt, and pilot test a stepped-care psychosocial intervention designed to improve emotional and behavioral health among children with leukemia in Pakistan. Children with leukemia may experience anxiety, depressive symptoms, irritability, sleep disturbance, social withdrawal, treatment-related distress, and behavioral difficulties during the cancer treatment pathway. In resource-constrained settings, structured psychosocial care is often limited or unavailable within routine pediatric oncology services. This study addresses this gap by developing a feasible, culturally responsive, and theory-informed intervention that can be delivered within existing clinical resources. The study follows a multi-stage intervention-development process guided by the Intervention Mapping framework and Medical Research Council guidance for complex interventions. The stages include: evidence review and expert consultation to identify gaps in current psychosocial care; mixed-methods needs assessment with children, caregivers, and healthcare professionals; refinement of the intervention through focus groups and an e-Delphi process; and pilot testing of the intervention in a two-arm pilot randomized controlled trial. The pilot trial will include children aged 7 to 14 years with leukemia who are clinically stable and in the remission or maintenance phase of treatment, together with their primary caregivers. Participants will be allocated to either the stepped-care intervention plus routine care or routine care alone. The stepped-care program is delivered over 12 weeks and progresses from low-intensity universal support to more intensive individualized care according to child and family needs. Intervention components include an information booklet, psychoeducational video, face-to-face psychoeducation, peer support, cognitive behavioral strategies, parent-child behavioral training, and one-to-one therapy or referral when indicated. The intervention will be delivered by trained mental health nurses under supervision of a psychologist. The primary focus of this pilot trial is feasibility and acceptability, including recruitment, retention, attendance, intervention fidelity, completion of outcome measures, and participant satisfaction. Secondary exploratory outcomes include emotional and behavioral functioning, distress, quality of life, depressive symptoms, sleep disturbance, treatment adherence, and family functioning. Findings will guide refinement of the intervention and inform the design of a future fully powered randomized controlled trial.

Status (registry)
Enrolling by invitation
Study type
Interventional
Enrollment
96 (estimated)
First submitted
16 Apr 2026
Start date
10 Jun 2025
Primary completion date
30 Mar 2026
Lead sponsor
Zhengzhou University
NCT number
NCT07587411

What you commit to

  • Study type: Interventional
  • Planned participants: 96
  • From 10 Jun 2025 to the primary completion date, 30 Mar 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Cognitive impairment preventing meaningful participation.
  • Severe mental health conditions (e.g., active psychosis, extreme depression) in the child.
  • Active substance abuse or impairing conditions in the primary carer.

Other

  • Acute medical instability requiring intensive care.
  • Non-primary carers without direct responsibility for the child's care.
  • Non-English/non-Urdu/Pashto-speaking participants.

Who the study is looking for

  • Children diagnosed with leukaemia (confirmed by medical records).
  • Aged between 7 and 14 years at the time of diagnosis.
  • Primary carers (parents, guardians, or immediate family members) who are directly involved in the child's care and treatment.
  • Ability to comprehend and communicate in the local language (e.g., Urdu, Pashto).
  • Child in the stable remission or maintenance phase of leukaemia treatment.
  • Willingness to participate in the study and provide informed consent (child assent and parental consent).

Age in the registry: 7 years to 14 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hayatabad Medical Complex
Coordinator of this site? Confirm its status
PeshawarPakistanUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.